Non-ownership Filings
| Imfinzi approved in EU for early gastric cancer | Mar. 16, 2026 |
| Notice of AGM | Mar. 10, 2026 |
| Total Voting Rights | Mar. 02, 2026 |
| AstraZeneca prices a $2bn bond offering | Feb. 26, 2026 |
| Filing of Form 20-F with SEC | Feb. 25, 2026 |
| Annual Financial Report | Feb. 24, 2026 |
| Directorate change | Feb. 24, 2026 |
Ownership Update Filings
| Director/PDMR Shareholding | Mar. 06, 2026 |
| Director/PDMR Shareholding | Mar. 06, 2026 |
| Director/PDMR Shareholding | Mar. 06, 2026 |
| Director/PDMR Shareholding | Dec. 22, 2025 |
| Director/PDMR Shareholding | Dec. 19, 2025 |
| Director/PDMR Shareholding | Nov. 14, 2025 |
| Director/PDMR Shareholding | Nov. 10, 2025 |